Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

846 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

NCT07545122

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +16 more
Locations
  • Tasman Oncology Research Gold Coast, Queensland, Australia
  • Calvary Mater Hospital Newcastle Newcastle, Queensland, Australia
  • Linear Clinical Research Perth, Western Australia, Australia
  • Sydney Adventist Hospital Wahroonga, New South Wales, Australia
View Trial Details
Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

NCT07029399

Conditions
Breast Diseases, Breast Neoplasms, CCNE1 Amplified Advanced Solid Tumors, +12 more
Locations
  • City of Hope Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT06084481

Conditions
Adenocarcinoma, Biliary Tract Cancers, Biliary Tract Diseases, +31 more
Locations
  • City of Hope National Medical Center /ID# 258645 Duarte, California, United States
  • University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926 Denver, Colorado, United States
  • Florida Cancer Specialists /ID# 261569 Sarasota, Florida, United States
View all 54 locations
View Trial Details
Recruiting

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

NCT07743190

Conditions
Breast Diseases, Breast Neoplasms, Elevated Tumor-Infiltrating Lymphocytes, +6 more
Locations
  • SUNY Upstate Medical University Syracuse, New York, United States
  • Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina, United States
View Trial Details

Related conditions